Polar Asset Management Partners’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-9,900
| Closed | -$2.29M | – | 825 |
|
|
2023
Q4 | $2.29M | Sell |
9,900
-400
| -4% | -$92.6K | 0.04% | 325 |
|
|
2023
Q3 | $1.5M | Sell |
10,300
-5,400
| -34% | -$789K | 0.03% | 406 |
|
|
2023
Q2 | $3.63M | Buy |
15,700
+11,800
| +303% | +$2.73M | 0.07% | 346 |
|
|
2023
Q1 | $945K | Hold |
3,900
| – | – | 0.01% | 536 |
|
|
2022
Q4 | $1.13M | Buy |
+3,900
| New | +$1.13M | 0.01% | 625 |
|
|
2022
Q2 | – | Sell |
-52,800
| Closed | -$5.18M | – | 1355 |
|
|
2022
Q1 | $5.18M | Hold |
52,800
| – | – | 0.06% | 389 |
|
|
2021
Q4 | $4.47M | Hold |
52,800
| – | – | 0.05% | 406 |
|
|
2021
Q3 | $4.21M | Buy |
52,800
+24,700
| +88% | +$1.97M | 0.04% | 395 |
|
|
2021
Q2 | $2.74M | Buy |
+28,100
| New | +$2.74M | 0.03% | 468 |
|